Finance

Lists
Why is DOSE down 8.33%?
Dive Deeper
DOSE:CNSX
Rapid Dose Therapeutics Corp
CA$0.11
-8.33%
(-0.0100) 1D
Sep 24, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for DOSE...
Open
CA$0.12
High
CA$0.12
Low
CA$0.11
Mkt. cap
15.16M
Avg. vol.
29.86K
Volume
9.00K
52-wk high
CA$0.19
52-wk low
CA$0.08
EPS
-CA$0.03
Open
CA$0.12
High
CA$0.12
Low
CA$0.11
Mkt. cap
15.16M
Avg. vol.
29.86K
Volume
9.00K
52-wk high
CA$0.19
52-wk low
CA$0.08
EPS
-CA$0.03
About Rapid Dose Therapeutics Corp
CEO-
Employees-
Founded2008
HeadquartersBurlington, Ontario, Canada
SectorPharmaceutical industry
Websiterapid-dose.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
672.92K
657.14K
660.52K
584.52K
Cost of goods sold
296.47K
347.34K
375.36K
272.66K
Cost of revenue
296.47K
347.34K
375.36K
272.66K
Research and development expenses
19.39K
15.20K
13.14K
-170.00
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
691.93K
792.49K
543.31K
419.38K
Operating expense
919.24K
998.15K
721.18K
539.58K
Total operating expenses
1.22M
1.35M
1.10M
812.25K
Operating income
-542.79K
-688.35K
-436.03K
-227.73K
Other non operating income
-
-
-
-
EBT including unusual items
-825.47K
-1.14M
-700.00K
-503.70K
EBT excluding unusual items
-825.47K
-1.14M
-700.00K
-503.70K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-825.47K
-1.14M
-700.00K
-503.70K
Net profit margin
-122.67%
-173.56%
-105.98%
-86.17%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-282.69K
-452.16K
-263.97K
-275.97K
Net interest expenses
-282.69K
-452.16K
-263.97K
-275.97K
Depreciation and amortization charges
135.20K
126.60K
117.86K
120.37K
EBITDA
-501.96K
-656.12K
-393.20K
-192.89K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps